This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Investigation Committee of the University of Colorado, Denver, USA, and the Editor. The Committee has come to the conclusion that author Kadam has knowingly and intentionally falsified and/or fabricated results by manipulating LC-MS/MS peak area data to smooth kinetics and/or alter statistical significance for Figure 6. The standard curve for the drug pazopanib was falsified to make it appear linear. In fact, the raw data for the standard curves were highly scattered and non-linear, resulting in an unusable standard curve. As a result, the pazopanib values calculated from the fabricated curve are completely unreliable. The Committee found no evidence that any of the other authors was aware of and/or participated in any activity amounting to Scientific Misconduct.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497139 | PMC |
http://dx.doi.org/10.1016/j.jconrel.2016.07.039 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!